They can, reduce hunger, increase feelings of fullness, slow down stomach emptying, and improve insulin sensitivity
In glucocorticoid-induced atrophy models (dexamethasone 1mg/kg/day for 7 days in rodents), IGF-1 LR3 (0.5-1mg/kg/day) reduced Atrogin-1 by 42-52% and preserved myofibre cross-sectional area (H&E gastrocnemius CSA 18% vs dexamethasone alone vs 6% with IGF-1 LR3 co-treatment)
I can have it evaluate estimated amounts of medication in my system with self-reported side effects to map trends so I can better predict how it will affect me (still new to the med)
That suggests that the ambulance didnt totally disintegrate
The Wegovy injection helped people lose an average of 21% or more of their starting weight after 72 weeks on the 7.2mg dose
Even a 0.5% reduction in A1c is considered clinically meaningful, as it can lower the risk of heart disease and other complications of T2D, such as kidney and nerve damage, so that level of reduction particularly on top of existing recommended treatment is a win